2nd Quarter - Report

PODESTA GROUP, INC. for MILLENNIUM PHARMACEUTICALS INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. 4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions 2008 Medicare Bill Comparative Effectiveness H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
RANDALL GERARD —
ANDREW KAUDERS Sr. Adv. Sen. Menendez; ED, House Demo Caucus
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson
LANTIE SLENZAK Legislative Director, Rep. Gene Green

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 3 (110th), S. 2029 (110th), H.R. 5480 (110th), S. 2662 (110th), H.R. 6331 (110th), H.R. 3162 (110th), S. 3101 (110th)

Pharmacy PHA

H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics

LobbyistCovered position, as disclosed
SHARON COHEN —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1956 (110th), S. 1505 (110th), H.R. 1038 (110th), S. 2029 (110th), S. 623 (110th), H.R. 5629 (110th), S. 1695 (110th)

Budget/Appropriations BUD

House Concurrent Resolution 312 FY09 Budget Resolution Senate Concurrent Resolution 70 FY09 Budget Resolution Drug Importation Comparative Effectiveness LHHS Appropriations - drug importation issues Homeland Appropriations - drug importation issues Agriculture Appropriations - drug importation issues

LobbyistCovered position, as disclosed
SHARON COHEN —
ANDREW KAUDERS Sr. Adv. Sen. Menendez; ED, House Demo Caucus
ELIZABETH ANN MORRA —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, entire bill H R. 1908, Patent Reform Act of 2007, entire bill

LobbyistCovered position, as disclosed
SHARON COHEN —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
TAKEDA PHARMACEUTICALS COMPANY LIMITED Japan Japan 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.